Bacolod to start vaccination of A4 residents | Inquirer News

Bacolod to start vaccination of A4 residents

/ 05:16 PM May 19, 2021

BACOLOD CITY –– This City’s Emergency Operations Center (EOC)  expects to begin the vaccination of residents under the A4 category by the end of the week, said Administrator Em Ang.

A4 covers frontline personnel in essential sectors, including uniformed employees.

The city government is using AstraZeneca vaccines for healthcare workers, seniors, and persons with medical conditions, said Ang, who is also EOC executive director.

ADVERTISEMENT

She said they expect to use up all their AstraZeneca vaccines this week and start with their Sinovac supply.

FEATURED STORIES

In Negros Occidental, Dr. Jessica Fama, medical specialist of the Provincial Health Office, said more than 22,700 people have been vaccinated against COVID-19 in the province as of May 17.

Gov. Eugenio Jose Lacson noted that the COVID-19 cases in Negros Occidental are going down.

Negros Occidental has 1,443 active COVID-19 cases as of Tuesday.

“I hope we can continue this downtrend, (but) just the same we still have to follow the minimum health protocols”, Lacson said.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: A4 category, Bacolod City, COVID-19, Em Ang, Philippine news updates, Regions, Vaccination

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.